Probiotic for Weight Management in Overweight and Obese Adults
Condition(s) studied
Investigational drug(s) / intervention(s)
Probiotic: The trial phase of this study lasted 12 weeks, and each patient will make 4 visits (week 0, week 4, week 8, week 12)
Placebo: The trial phase of this study lasted 12 weeks, and each patient will make 4 visits (week 0, week 4, week 8, week 12)
Study summary
To evaluate the impact of pasteurized Akkermansia muciniphila Akk11 capsules versus placebo on body composition (including body weight, BMI, body fat percentage, waist-to-hip ratio, wrist circumference, visceral fat area, and basal metabolic rate) and serum lipid parameters (TC, LDL-C, HDL-C, and TG) in overweight and obese adults.
Eligibility
Primary outcome measure(s)
- Change from baseline in body weight following the intervention — Baseline (Week 0) and Weeks 4, 8, and 12
Body weight will be assessed using a calibrated digital scale under standardized conditions
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| The School of Food and Bioengineering, Henan University of Science and Technolog | Luoyang | Henan |
More Wecare Probiotics Co., Ltd. trials in China
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07507929 on ClinicalTrials.gov ↗ ← All trials in China